Importantly, the chemical inhibition of autophagy/mitophagy selectively limits lung cancer cell growth driven by TP53-p.Glu358Val mutation, suggesting that autophagy/mitophagy is a druggable target for lung cancers with a loss-of-function mutation of TP53 (Figure S3). Here, TP53 is linked to lung carcinoma.